Clinical Trials Browser

Phase 2/3 × OTHER × MAGEA3 protein, human × Clear all

NCT00090493 2013-06-24

Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma

Phase 2/3 Completed

4 enrolled 6 charts

Multiple Myeloma, Neoplasms, Plasma Cell